Slide Background
TEST LIST
CPT code TEST NAME LAB TEST CODE Turn Around Time Test Description Indication Sample requirment No. of genes somatic vs. germline
81201-81203, 81292-81300, 81307, 81308, 81317-81319, 81321-81323, 81351, 81432, 81433, 81435, 81436, Heredigene Cancer Hereditary panel 1482 25 - 35 days Comprehensive NGS analysis of 43 genes that are related to Hereditary Cancer Syndromes Hereditary Cancer Syndromes Blood in EDTA (2 vials X 2ml) 43 germline
81445, 81210, 81233, 81235, 81237, 81246, 81120, 81121, 81270, 81272, 81273, 81275, 81276, 81479, 81305, 81311, 81314, 81309, 81345, 81455 Mo.Re 1980 15 - 20 days All solid tumors, NGS, multi-gene assay covers 147 genes and 51 fusion transcripts to provide an insight to the tumor biology to provide individualised treatment options. all solid tumors Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 161 somatic
Please contact customer service Prime 2620 15 - 20 days Comprehensive Genomic profiling based on DNA and RNA analysis for 500+ genes. Tissue in paraffin /3 unstained Sections 3μm & 5 unstained sections 10μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles all solid tumors Tissue in paraffin /3 unstained Sections 3μm & 5 unstained sections 10μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles 513 somatic
81210, 81235, 81275, 81276, 81301, 81311, 81309, 81352 Com.Pl.t.DX colon 2426 10-18 days Colon Cancer Panel:24 gene+ 6 fusions panel +MSI. Somatic mutation detection from FFPE sample colon cancer Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 28 somatic
81210, 81235, 81275, 81276, 81311, 81309, 81352 Com.Pl.t.DX lung 2427 10-18 days Lung Cancer Panel: 24 gene+ 6 fusions panel. Somatic mutation detection from FFPE samples Lung Cancer Tissue in paraffin /5 unstained Sections 3μm & 6 unstained sections 10μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles 28 somatic
81204 , 81210 , 81168 , 81235 , 81246 , 81120 , 81121 , 81272 , 81273 , 81275 , 81276 , 81311 , 81314 , 81309 , 81347 , 81455 , 81445 , 81479 , 81351 , 81352 ,  Com.pl.i.t DX Liquid Comprehensive  2217 15 - 20 days NGS Analysis: 50 Genes and 12 Fusion Transcripts all solid tumors Whole Periferal Blood in DNA BCT and RNA BCT Streck tube 50 somatic
n/a Tumor Mutational Burden (TMB) 2128 10-18 days NGS analysis agnostic marker (all solid tumors) Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 409 somatic
n/a RET fusions 2912 7 - 13 days NGS analysis lung, thyroid  Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm n/a somatic
81120, 81121, 88381 IDH 1/2 MUTATION 1085 7 - 13 days NGS analysis  Brain tumors / Acute Myeloid leukemia / cholangiocarcinoma Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 2 somatic
81210 BRAF V600Eexon 11and 15 0208 10-18 days NGS analysis  Melanoma, Colon Cancer and lung cancer Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 1 somatic
81377(x1) , 88377 1p19q by Fluorescent in situ hybridization (FISH) 2635 7 - 13 days Fluorescent In Situ Hybridization Brain tumors Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles n/a somatic
81272  C-KIT gene exons 9, 11, 13, 17 0028 10-18 days NGS analysis  on-label Gist tumors and off-label melanoma Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 1 somatic
n/a EWS-WT1 - t(11;22) 0541 7 - 13 days Fluorescent In Situ Hybridization Sarcoma Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm n/a somatic
88377 N-MYC by Fluorescent in situ hybridization (FISH) 1821 10 -18 days Fluorescent In Situ Hybridization Neuroblastoma Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles 1 somatic
88271 x2 , 88274  Her2/Neu by Fluorescent in situ hybridization (FISH) - (breast) 2019 7 - 13 days Fluorescent In Situ Hybridization Breast CA Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles 1 somatic
88271 x2 , 88274  Her2/Neu by Fluorescent in situ hybridization (FISH) - (stomach) 2019 7 - 13 days Fluorescent In Situ Hybridization Stomach CA Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles 1 somatic
81235 EGFR gene exons 18, 19, 20, 21 0030 10 -18 days NGS analysis  Lung Cancer Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 1 somatic
n/a EML4-ALK by Fluorescent in situ hybridization (FISH) 1201 10 -18 days Fluorescent In Situ Hybridization Lung Cancer Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles n/a somatic
n/a ROS-1 by Fluorescent in situ hybridization (FISH) 1880 10 -18 days Fluorescent In Situ Hybridization Lung Cancer Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles n/a somatic
88360 PD-L1 by IHC  in Triple- Negative Breast Carcinoma (TNBC) SP142 2250 7 - 13 days Immunohistochemistry analysis Triple Negative Breast Carcinoma Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles 1 somatic
88360 PD-L1 by IHC  in Triple- Negative Breast Carcinoma (TNBC) 22C3 2250 7 - 13 days Immunohistochemistry analysis Triple Negative Breast Carcinoma Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles 1 somatic
n/a PIK3CA gene, exons 9,13,17,20 1243 7 - 13 days NGS analysis  All solid tumors (on-label indication for Breast CA) Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 1 somatic
n/a PIK3CA gene Liquid Biopsy exons 9,13,17,20 2430 7 - 13 days NGS analysis  All solid tumors (on-label indication for Breast CA) Whole Peripheral Blood in DNA BCT Streck tube 1 somatic
81275, 81276 K-RAS gene exons 2, 3, 4 1379 10 -18 days NGS analysis  Colon Cancer and Lung Cancer Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 1 somatic
81275, 81276 , 81311, 81210 K-RAS gene exons 2, 3, 4 & NRAS gene exons 2, 3, 4/B_RAF exon 11,15 1380 10 -18 days NGS analysis  Colon Cancer Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 3 somatic
81311 N-RAS gene Exons 2,3,4, 1244 10 -18 days NGS analysis  Colon Cancer  Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 1 somatic
n/a Synovial Sarcoma 0542 7 - 13 days NGS analysis fro translocation Synovial Sarcoma Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 2 somatic
81162-81367, 81212, 81215, 81216, 81217 BRACA 1/2 somatic 1676 10 -18 days Full Sequencing, via NGS of BRCA1 and BRCA2 genes  on-label Ovarian CA. and Prostate CA Also Breast CA and Pancreatic Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 2 somatic
81162-81367, 81212, 81215, 81216, 81217 BRCA1/2 full analysis Germ Line 2037 15 - 20 days Full Sequencing, via NGS of BRCA1 and BRCA2 genes Hereditary Breast/Ovarian/pancreatic and Prostate Cancer Blood in EDTA (2 vials X 2ml) 2 germline
81217 MGMT methylation 0395 10 -18 days Methylation specific Real - Time PCR Brain tumor Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm n/a somatic
81210 BRAF gene exons 11 and 15 reflex 1507 10 -18 days NGS analysis  Melanoma,  Colon Cancer and Lung CA Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 1 somatic
81314 PDGFRA gene exams 12,14,18 1750 7 - 13 days NGS analysis  Gist tumors Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 1 somatic
n/a Single gene Liquid biopsy DNA 1753 10 -18 days NGS analysis  all solid tumors Whole Peripheral Blood in DNA BCT Streck tube 1 somatic
n/a Single gene Liquid biopsy RNA 2073 10 -18 days NGS analysis  all solid tumors Whole Peripheral Blood in RNA BCT Streck tube 1 somatic
81194 NTRK1,2,3 2239 7 - 13 days NGS analysis agnostic marker (all solid tumors) Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm n/a somatic
81403, 81404, 81405 FGFR1, FGFR2, FGFR3 genes by NGS 2646 10 -18 days NGS analysis cholagiocarcinoma (FGFR2 fusions on-label indication) and urothelial CA (on-label mutations) Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm 3 plus fusions somatic
n/a C-met exon 14 skipping mutations/amplification Liquid Biopsy 3073 7 - 13 days NGS analysis Lung cancer Whole Peripheral Blood in DNA BCT 1 somatic
88381, 81301 Microsatellite instability (MSI) by NGS 0025 7 - 13 days NGS analysis agnostic marker (all solid tumors) Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm   somatic
n/a PD-L1   7 - 13 days Immunohistochemistry analysis Immunotherapy marker (all solid tumors) Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles 1 somatic